While the IRE1-XBP1 splicing activity favours angiogenesis and higher expression of migration/invasion markers, IRE1-RIDD activity promotes attenuation of both responses in tumour cells, pointing to antagonistic roles of the two signalling outputs in GBM progression. Here, ERN1 is linked to glioblastoma.